Who are betamethasone and Ropivacaine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Hydrocortisone acetate and lidocaine hydrochloride.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/betamethasone-and-ropivacaine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

betamethasone and Ropivacaine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

betamethasone and Ropivacaine (betamethasone and Ropivacaine) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid and Local anesthetic. Area: Pain management.

phase 3 Corticosteroid and Local anesthetic Pain management Small molecule Live · refreshed every 30 min

Target snapshot

betamethasone and Ropivacaine (betamethasone and Ropivacaine) — Biobizkaia Health Research Institute. Betamethasone is a corticosteroid that reduces inflammation, while Ropivacaine is a local anesthetic that blocks nerve signals.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
betamethasone and Ropivacaine TARGET	betamethasone and Ropivacaine	Biobizkaia Health Research Institute	phase 3	Corticosteroid and Local anesthetic
Hydrocortisone acetate and lidocaine hydrochloride	Hydrocortisone acetate and lidocaine hydrochloride	Citius Pharmaceuticals, Inc.	marketed	Topical corticosteroid and local anesthetic combination	Glucocorticoid receptor (hydrocortisone); voltage-gated sodium channels (lidocaine)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid and Local anesthetic class)

Biobizkaia Health Research Institute · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). betamethasone and Ropivacaine — Competitive Intelligence Brief. https://druglandscape.com/ci/betamethasone-and-ropivacaine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab